19-21726694-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173531.4(ZNF100):āc.1618C>Gā(p.Leu540Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00033 in 1,605,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_173531.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF100 | NM_173531.4 | c.1618C>G | p.Leu540Val | missense_variant | 5/5 | ENST00000358296.11 | NP_775802.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF100 | ENST00000358296.11 | c.1618C>G | p.Leu540Val | missense_variant | 5/5 | 1 | NM_173531.4 | ENSP00000351042.5 | ||
ZNF100 | ENST00000305570.10 | c.1426C>G | p.Leu476Val | missense_variant | 4/4 | 1 | ENSP00000445201.3 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152100Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000211 AC: 51AN: 241554Hom.: 0 AF XY: 0.000183 AC XY: 24AN XY: 131190
GnomAD4 exome AF: 0.000336 AC: 488AN: 1453622Hom.: 0 Cov.: 30 AF XY: 0.000303 AC XY: 219AN XY: 722870
GnomAD4 genome AF: 0.000276 AC: 42AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.000296 AC XY: 22AN XY: 74410
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.1618C>G (p.L540V) alteration is located in exon 5 (coding exon 5) of the ZNF100 gene. This alteration results from a C to G substitution at nucleotide position 1618, causing the leucine (L) at amino acid position 540 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at